Catherine Lam

    Catherine G. Lam, MD, MPH

    Assistant Member, St. Jude Faculty
    Medical Director, Philippines Program and Asian Development, International Outreach Program

    Departments

    Oncology

    Divisions

    Solid Tumor

    Contact Information

    Catherine Lam, MD, MPH
    Oncology
    MS 721, Room S2014B
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: catherine.lam@stjude.org
    Phone: (901) 595-2094
    FAX: (901) 595-5319

    Education

    BSc – Trinity College, University of Toronto, Canada (2000)
    MD – University of Toronto, Canada (2004)
    MPH – Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (2010)


    Research Interests


    Selected Publications

    Vern-Gross TZ, Lam CG, Graff Z, Singhal S, Levine DR, Gibson D, Coan A, Anghelescu DL, Yuan Y, Baker JN. Patterns of End-of-Life Care in Children with Advanced Solid Tumor Malignancies Enrolled on a Palliative Care Service. J Pain Symptom Manage Apr 16, 2015. Epub ahead of print. pii:S0885-3924(15)00171-2. doi:10.1016/j.jpainsymman.2015.03.008.

    Parikh NS, Howard SC, Chantada G, Israels T, Khattab M, Alcasabas P, Lam CG, Faulkner L, Park JR, London WB, Matthay KK. SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer Mar 21, 2015. Epub ahead of print. doi:10.1002/pbc.25501.

    Weaver MS, Howard SC, Lam CG. Defining and Distinguishing Treatment Abandonment in Patients With Cancer. J Pediatr Hematol Oncol Mar 6, 2015. Epub ahead of print. doi:10.1097/MPH.0000000000000319.

    Weaver MS, Arora RS, Howard SC, Salaverria CE, Liu YL, Ribeiro RC, Lam CG. A practical approach to reporting treatment abandonment in pediatric chronic conditions. Pediatr Blood Cancer 62(4):565-70, 2015. doi:10.1002/pbc.25403.

    Caruso Brown AE, Howard SC, Baker JN, Ribeiro RC, Lam CG. Reported Availability and Gaps of Pediatric Palliative Care in Low- and Middle-Income Countries: A Systematic Review of Published Data. J Palliat Med 17(12):1369-1383, 2014.

    Weaver MS, Heminger CL, Lam CG. Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes. BMC Public Health 14(1):944, 2014.

    Lam CG, Furman WL, Wang C, Spunt SL, Wu J, Ivy P, Santana VM, McGregor LM. Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors. J Pediatr Hematol Oncol June 17, 2014.

    Weaver MS, Lam CG. Improving retinoblastoma outcomes through a stage-based intervention model. Lancet Glob Health 2(3):E143, 2014.

    Levine D, Lam CG, Cunningham MJ, Remke S, Chrastek J, Klick J, Macauley R, Baker JN. Best practices for pediatric palliative cancer care: a primer for clinical providers. J Support Oncol 11(3):114-25, 2013.

    Lam CG, Cohen KJ, Roter DL. Coping Needs in Adolescents with Cancer: A Participatory Study. J Adolesc Young Adult Oncol 2(1):10-16, 2013.

    Gupta S, Yeh S, Martiniuk A, Lam CG, Chen HY, Liu YL, Tsimicalis A, Arora RS, Ribeiro RC. The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middle-income countries: A systematic review and meta-analysis. Eur J Cancer 2013 Apr 15. doi:pii: S0959-8049(13)00258-X. 10.1016/j.ejca.2013.03.024.

    Lam CG, Roter DL, Cohen KJ. Survey of Quality, Readability, and Social Reach of Websites on Osteosarcoma in Adolescents. Patient Educ Couns 90(1):82-87, 2013. First published Sep 4, 2012, http://dx.doi.org/10.1016/j.pec.2012.08.006.

    Lam CG, Rossell N, Ribeiro RC. Global Snapshots of Treatment Abandonment in Children and Adolescents with Cancer: Social Factors, Implications, and Priorities. J Healthcare, Science and Humanities 2(1):81-110, 2012.

    Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM. Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis 70(12):2089-2094, 2011.

    Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, Kaur G, Koodiyedath B, Kulkarni K, Lam C, Luna-Fineman S, Pizer B, Rivas S, Rossell N, Sitaresmi MN, Tsimicalis A, Weaver M, Ribeiro RC. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol Aug;12(8):719-20, 2011.

    Lam C, Bouffet E, Tabori U, Mabbott D, Taylor M, Bartels U. Rapamycin (Sirolimus) in Tuberous Sclerosis Associated Pediatric Central Nervous System Tumors, Pediatric Blood & Cancer Mar;54(3):476-9, 2010.

    Lam C, Bouffet E, Bartels U. Nimotuzumab in Pediatric Glioma. Future Oncology 5(9):1349-1361, 2009.

    Porepa M, Lam C, Huber J, Au H, Birken C. Kids on Kids’ Health: Creating a Child Health Magazine with Students from an Urban, Multicultural, Low Income Elementary School. Paediatrics & Child Health Apr; 14(4):219-221, 2009.

    Dipchand A, Friedman J, Bismilla Z, Gupta S, Lam C. The Hospital for Sick Children Handbook of Pediatrics, 11th Edition, Elsevier Sciences, 2009.

    Pullenayegum EM, Lam C, Manlhiot C, Feldman BM. Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting. J Clin Epidemiol Sep;61(9):875-81, 2008.

    Lam C, Tjon J, Hamilton J, Ahmet A. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature. Pharmacotherapy Dec;26(12):1811-5, 2006.

    Lam C, Young N, Marwaha J, McLimont M, Feldman BM. Revised versions of the Childhood Health Assessment Questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effect. Arthritis & Rheumatism Dec15;51(6):881-9, 2004.

    Lam C, Badiwala M, Froeschl M. Morning Report: Truth serum. Univ Tor Med J Mar;79(2):136-141, 2002.

    Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nature Medicine Jun;6(6):698-702, 2000.

    Last update: January 2015